基因组测序对胎儿结构异常产前诊断的诊断率
该前瞻性队列对37例超声发现结构异常的单胎胎儿行基因组测序(GS >30x),并与标准诊断检测平行进行。GS检出5例(14%)诊断性序列变异,另7例(19%)为可能解释表型的不确定意义变异,同时检出微阵列报告的全部致病性变异(2个拷贝数变异,5%)。产前GS对结构异常胎儿的诊断率为19%。
要点
- 产前GS对结构异常胎儿的诊断率为19%(序列变异加拷贝数变异)。
- GS检出5例(14%)致病性序列变异,涉及NIPBL、FOXF1、RERE、AMMECR1和FLT4。
- GS检出微阵列报告的全部致病性拷贝数变异(2个,5%)。
核心结论
- 产前GS对结构异常胎儿的诊断率为19%(序列变异加拷贝数变异)。
- GS有潜力替代多项连续检测(微阵列、基因面板和外显子组测序),以及时提供产前诊断所需的最全面分析。
研究设计与样本
- 对37例超声发现结构异常并接受侵入性产前检测的单胎胎儿行基因组测序(GS >30x)的前瞻性队列研究。
- GS与标准诊断检测平行进行,优先变异按ACMG指南分类,并由认证实验室和临床遗传学家组成的专家组审核。
主要发现
- 5例胎儿(14%)检出诊断性序列变异,致病性变异位于NIPBL、FOXF1、RERE、AMMECR1和FLT4。
- 另有7例胎儿(19%)检出可能解释表型的不确定意义变异(VUS)。
- GS检出临床微阵列报告的全部致病性变异(2个拷贝数变异,5%)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Genome sequencing (GS >30x) is beginning to be adopted as a comprehensive genome-wide test for the diagnosis of rare disease in the post-natal setting. Recent studies demonstrated the utility of exome sequencing (ES) in prenatal diagnosis, we investigate the potential benefits for GS to act as a comprehensive prenatal test for diagnosis of fetal abnormalities. METHODS: We performed GS on a prospective cohort of 37 singleton fetuses with ultrasound-identified structural abnormalities undergoing invasive prenatal testing. GS was performed in parallel with standard diagnostic testing, and the prioritized variants were classified according to ACMG guidelines and reviewed by a panel of board-certified laboratory and clinical geneticists. RESULTS: Diagnostic sequence variants were identified in 5 fetuses (14%), with pathogenic variants found in NIPBL, FOXF1, RERE, AMMECR1, and FLT4. A further 7 fetuses (19%) had variants of uncertain significance (VUS) that may explain the phenotypes. Importantly, GS also identified all pathogenic variants reported by clinical microarray (2 CNVs, 5%). CONCLUSION: Prenatal GS offered diagnoses (sequence variants and CNVs) in 19% of fetuses with structural anomalies. GS has the potential of replacing multiple consecutive tests, including microarray, gene panels, and WES, to provide the most comprehensive analysis in a timely manner necessary for prenatal diagnosis.
引用
- Wang Y, Greenfeld E, Watkins N, et al. Diagnostic yield of genome sequencing for prenatal diagnosis of fetal structural anomalies. Prenat Diagn. 2022. PMID: 35089622. doi:10.1002/pd.6108
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。